Skip to main content
Premium Trial:

Request an Annual Quote

Howard McLeod, Geoffrey Harris

Cancer Genetics has added Howard McLeod and Geoffrey Harris to its board of directors.

McLeod is the medical director of the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He joined Moffitt last year from the University of North Carolina's Institute for Pharmacogenomics and Individualized Therapy, of which he was the founding director.

Harris is a portfolio manager and managing partner at c7 Advisors, a healthcare advisory firm. Before c7 Advisors, Harris was managing director and co-head of the Cantor Fitzgerald Healthcare Investment Group from 2011 to 2014.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more